STUDresearch · Non-peptide
Empagliflozin
Also known as
Jardiance · SGLT2 inhibitor empagliflozin · empa · Jardiance 10 mg · Jardiance 25 mg
Community talk. May be wrong. Not medical advice. Not a protocol. Not for human or animal use.
Non-peptide
Lots of talk
Systemic
Oral
Metabolic & longevity adjacents
Systemic oral SGLT2 inhibitor.
What people say
Empagliflozin, sold as Jardiance, is a prescription oral SGLT2 inhibitor that increases urinary glucose excretion. It is not a peptide or GLP-1 drug; its labeled uses concern diabetes, heart failure and kidney outcomes.
Doses people talk about
These are oral prescription amounts and evidence labels, not a longevity or sick-day protocol. Rejected amount confusion: 100 mg is not an empagliflozin tablet band. The profile explicitly distinguishes empagliflozin milligrams from metformin-style gram dosing.
How it may feel
Inspected reports ranged from extra urination and thirst to no noticeable issues, recurrent thrush or perceived glucose improvement. One serious same-class account described euglycemic ketoacidosis after illness and declining intake. These reports do not define one normal felt window.
Labeled tablet amounts10 mg once daily; 25 mg in some type 2 diabetes uses
The product label supplies 10 mg and 25 mg tablets.
Off-label longevity discussion10 mg daily is commonly copied
Community repetition of the lower labeled tablet amount is not evidence for a longevity indication or protocol.
Half-life & effect duration
- Half-life in the body
- JardianceAbout 12.4 hours
- Felt duration people report
- Common discussionMore urination or thirst; some report no issues
- Other accountsRecurrent thrush, or worsening illness and appetite over weeks
Cycles people discuss
Labeled therapy is daily and chronic, not a short cut cycle. The profile separately preserves sick-day interruption context for dehydrating illness; that safety pause is not a cyclical longevity regimen.
Timing
Empagliflozin’s apparent terminal half-life is about 12.4 hours, and increased urinary glucose and volume can occur on the first day. That pharmacology does not establish how long thirst, urination changes or other subjective effects will be noticed.
Stacks
Clinical regimens may include metformin, a GLP-1 drug or blood-pressure medicines. Longevity screenshots add statins or rapamycin, while the profile rejects combining two flozins; multi-drug use weakens attribution.
Watch for
Euglycemic DKA — rare, serious, sick-day.
Tap a line to jump into the full notes. Research only — may be wrong.
Timing context & sources
Half-life in the body
Empagliflozin’s apparent terminal elimination half-life is approximately 12.4 hours.
The JARDIANCE label reports peak plasma concentration at about 1.5 hours and describes increased urinary glucose excretion; a 25 mg study recorded a day-1 urine-volume increase of 341 mL versus 135 mL on day 5.
Label pharmacokinetics and urine-volume measurements do not determine subjective thirst, urination burden, infection timing or outcome-trial benefit for an individual.
- DailyMed — JARDIANCE (empagliflozin) tablets (opens in a new tab)Dosage and Clinical Pharmacology: 10 mg and 25 mg oral tablets; median Tmax about 1.5 hours; apparent terminal half-life about 12.4 hours; day-1 urine-volume change described for 25 mg.Prescribing information supports labeled identity and measured pharmacology, not an off-label longevity indication or individual felt-duration estimate.
Felt duration people report
The inspected community reports do not establish one usual felt-duration window.
People reported increased urination or thirst, no issues, recurrent thrush and glucose changes. A separate same-author account described illness, worsening appetite and urination over weeks before hospitalization for ketoacidosis with a reported glucose value of 190 mg/dL.
These are self-reports with different diseases, co-medications and infection or illness contexts. The serious case is a warning signal, not a normal time course or a pharmacokinetic measurement.
- Reddit r/diabetes_t2 — Jardiance, yah or nay (opens in a new tab)Multiple comments report increased urination or thirst, no issues, recurrent thrush and perceived glucose improvements, often alongside other diabetes treatments.Different users, diseases, co-medications and durations; self-selection and no product or outcome verification prevent a single causal or timing estimate.
- Reddit r/diabetes — Ketoacidosis from Jardiance this past week (opens in a new tab)Original post and same-author replies describe a 57-year-old after about five years of Jardiance use, illness and declining intake or urination over four to five weeks, then hospitalization for ketoacidosis with reported glucose around 190 mg/dL.Single retrospective self-report without medical records; it cannot establish incidence, full diagnostic context or a normal felt-duration window.
What people say
- Attia-adjacent “if I could only pick one drug” lists often put an SGLT2 next to a statin / BP agent. That is podcast ranking, not a protocol. forum
- Not a ketone carnival on purpose — some see higher ketones; that is a side path, not the brand. forum
- EMPA-REG / heart-failure / kidney programs: The reason longevity Twitter stole a diabetes drug. Outcome trials, labeled uses — not a biohacker n=1. trial
- A1c drop in T2D — the original job. trial
- Weight: modest in the inserts. Not tirz. trial
Doses people talk about
- Not metformin grams. Not empa 100 mg. forum
- Do not combine with a crash-keto sick week without the sick-day talk. forum
- Longevity n=1s usually photocopy 10 mg. Still a prescription. forum
- Framing: Labeled milligrams — not a longevity protocol, not a research-chem scoop. forum
- Labeled: 10 mg oral daily; 25 mg in some T2D arms. trial
How it may feel
- Week 1: Extra bathroom trips. Thirst. forum
- Energy: some feel nothing; some feel lighter. anecdote
- Stop: sugars and the pee-glucose leave; no GLP rebound hunger story. forum
- Yeast / UTI meme is the side people actually name. trial
- Euglycemic DKA is the rare emergency the inserts shout about — sick-day rules, not a gym hack. trial
Cycles people discuss
- Longevity off-label talk is open-ended too — that is the controversy, not a 8-week blast. forum
- Not a cut cycle. forum
- Daily, chronic in the labeled diseases. trial
- Sick days: the insert says pause in some dehydrating illness. People who skip that show up in DKA case reports. trial
Timing
- Once-daily tablet. Morning with or without food in patient talk. forum
- Metformin t½ is not this t½. forum
- Glucose-in-urine is same-day. Outcome-trial clocks are years. trial
- Volume depletion is the first-week kidney-number scare. trial
More on what it is
- Why people talk about it: Attia / longevity slides as the diabetes drug with heart-and-kidney outcome trials. r/PeterAttia, r/diabetes, “poor man’s rapamycin” jokes. forum
- Vs metformin: Metformin is the AMPK / first-line T2D story. This is the flozin. Different side (yeast vs metformin GI). forum
- Vs semaglutide: Not a GLP. No food-noise diary like a weekly pin. Some people are on both in clinic. forum
- Not a fat-loss peptide. A few pounds in trials; the longevity crowd wants the outcome papers, not a cut. forum
- What it is: Jardiance — a prescription SGLT2 inhibitor tablet, 10 mg and 25 mg. You pee extra sugar. Not a peptide. trial
- How it works (plain): Blocks the kidney pump that reabsorbs glucose (SGLT2). Some glucose leaves in urine. Calories and blood sugar drop a bit; the labeled wins were heart failure and kidney outcomes in trial programs. trial
Stacks
- Longevity screenshot: statin + SGLT2 + rapamycin. Three jobs, noisy. forum
- Not stacked with another flozin. forum
- Clinic: with metformin, with a GLP, with BP meds — clinician territory. trial
Storage notes
- Pharmacy bottle. forum
- Jardiance vs a research “SGLT2 powder” — identity, don’t. forum
Watch for
- Dehydration / dizziness week one. forum
- Not a research-chem powder. Prescription. forum
- Genital yeast / UTI. The loud side. trial
- Euglycemic DKA — rare, serious, sick-day. trial
- Fournier’s gangrene is on the insert. Rare. Named so it is not a surprise. trial
- Kidney numbers can wiggle at start. trial
Evidence mix
Mixed trial + community tags
Full: every bullet (trial + community). Use Scan for a faster bro-science read.